|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004482,
umls-concept:C0008976,
umls-concept:C0010346,
umls-concept:C0023175,
umls-concept:C0034656,
umls-concept:C0039902,
umls-concept:C0087111,
umls-concept:C0205177,
umls-concept:C0205191,
umls-concept:C0544452,
umls-concept:C1274040,
umls-concept:C1442989,
umls-concept:C1521828,
umls-concept:C2587213
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-6-21
|
|
pubmed:abstractText |
A prospective randomized trial in patients with Crohn disease studied whether 6-thioguanine nucleotide (6-TGN) concentration-adapted azathioprine (AZA) therapy is clinically superior to a standard dose of 2.5 mg/kg/day AZA.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0009-9147
|
|
pubmed:author |
pubmed-author:AdlerGuidoG,
pubmed-author:ArmstrongVictor WVW,
pubmed-author:BehrensChristophC,
pubmed-author:BiasPeterP,
pubmed-author:HerfarthHansH,
pubmed-author:KruisWolfgangW,
pubmed-author:OellerichMichaelM,
pubmed-author:ReinshagenMaxM,
pubmed-author:SchützEkkehardE,
pubmed-author:ShipkovaMariaM,
pubmed-author:StallmachAndreasA,
pubmed-author:SteinJürgenJ,
pubmed-author:von AhsenNicolasN,
pubmed-author:von TirpitzChristianC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1306-14
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17495015-6-Mercaptopurine,
pubmed-meshheading:17495015-Adolescent,
pubmed-meshheading:17495015-Adult,
pubmed-meshheading:17495015-Aged,
pubmed-meshheading:17495015-Crohn Disease,
pubmed-meshheading:17495015-Dose-Response Relationship, Drug,
pubmed-meshheading:17495015-Drug-Induced Liver Injury,
pubmed-meshheading:17495015-Erythrocyte Indices,
pubmed-meshheading:17495015-Female,
pubmed-meshheading:17495015-Genotype,
pubmed-meshheading:17495015-Guanine Nucleotides,
pubmed-meshheading:17495015-Humans,
pubmed-meshheading:17495015-Leukopenia,
pubmed-meshheading:17495015-Male,
pubmed-meshheading:17495015-Methyltransferases,
pubmed-meshheading:17495015-Middle Aged,
pubmed-meshheading:17495015-Remission Induction,
pubmed-meshheading:17495015-Thionucleotides,
pubmed-meshheading:17495015-Thrombocytopenia
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
|
|
pubmed:affiliation |
Department of Medicine I, Klinikum Braunschweig, Braunschweig, Germany. m.reinshagen@klinikum-braunschweig.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
